Luciferase reporter mycobacteriophage (TM4::GeNL) enables rapid assessment of drug susceptibilities and inducible macrolide resistance in Mycobacterium abscessus complex

ABSTRACT Mycobacterium abscessus (MAB) infections are challenging to treat due to high-level resistance to anti-tuberculosis drugs, carbapenems, fluoroquinolones, and tetracyclines. Clarithromycin and amikacin are considered cornerstone drugs for MAB treatment due to their superior efficacy; however...

詳細記述

書誌詳細

主要な著者:	Saranathan Rajagopalan, Lahari Das, Donna J. Kohlerschmidt, Amy K. Rourke, Salika M. Shakir, Michelle H. Larsen, Max R. O’Donnell, Wendy A. Szymczak, Vincent E. Escuyer, Phyu M. Thwe, William R. Jacobs
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology 2025-09-01
シリーズ:	Journal of Clinical Microbiology
主題:	Mycobacterium abscessus inducible macrolide resistance amikacin luciferase reporter mycobacteriophage erm(41)
オンライン･アクセス:	https://journals.asm.org/doi/10.1128/jcm.00841-25
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!